Dog Vaccines Global Market Report 2023 - Market Size, Trend Analysis, Share, SWOT Analysis 2023 To 2032

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Dog Vaccines Global Market Report 2023 identifies rise in the adoption of pet dogs as the major driver for the dog vaccines market's growth in the forecast period. A pet dog refers to a companion animal that is domesticated or tamed and lives within a home. A dog vaccine is an injection that is given to dogs in series starting at the puppy stage and continuing into adulthood. This vaccine stimulates the immune system which helps dogs to encounter microorganisms and not get sick or have less severe symptoms.

The global dog vaccines market size is expected to grow from $3.23 billion in 2022 to $3.42 billion in 2023 at a compound annual growth rate (CAGR) of 6.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The dog vaccines market size is expected to grow to $4.14 billion in 2027 at a CAGR of 4.9%.

Download Free Sample Of Dog Vaccines Market Report -
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8443

Major competitors in the dog vaccines market are Bayer AG, Vetoquinol S.A, Boehringer Ingelheim, Ceva Sante Animale, Heska Corporation, Merck & Co Inc., Virbac, Elanco Animal Health Incorporated.

A key trend in the dog vaccines market includes Major companies operating in the dog vaccine market are advancing toward the use of novel technology for vaccine development. For instance, in September 2022, Merck Animal Health, a US-based company providing veterinary pharmaceuticals, vaccines, and technology solutions, launched Nobivac Intra-Trac Oral BbPi, the first oral vaccine with mucosal protection and easy oral administration. It is used for the vaccination of healthy dogs aged 7 weeks or older against canine parainfluenza virus and Bordetella bronchiseptica. Additionally, it includes the novel technology, Immuno-Mist-R technology by Intervet, a Merck & Co subsidiary. This revolutionary technology, Immuno-Mist-RTM, dramatically increases mucosal surface area contact.

Read More On The Global Dog Vaccines Market Report Here:
https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

The dog vaccines market is segmented -
1) By Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines

2) By Route Of Administration: Subcutaneous, Intramuscular, Intranasal

3) By Application: Below 6 Months, Above 6 Months

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. Asia-Pacific was the largest region in the dog vaccines market.

The Business Research Company's "Global Dog Vaccines Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Dog Vaccines Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8443

The Table Of Content For The Dog Vaccines Market Include:
1. Executive Summary
2. Dog Vaccines Market Characteristics
3. Dog Vaccines Market Trends And Strategies
4. Dog Vaccines Market - Macro Economic Scenario
5. Dog Vaccines Market Size And Growth
……….
26. Africa Dog Vaccines Market
27. Dog Vaccines Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Dog Vaccines Market
29. Dog Vaccines Market Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.